Karol Granados
Mannheim, BW 68167, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor.
Journal: International journal of cancer
Published: December 23, 2020
Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.
Journal: International journal of molecular sciences
Published: October 09, 2020
T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells.
Journal: British journal of cancer
Published: July 29, 2019
Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
Journal: International journal of cancer
Published: February 21, 2019
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.
Journal: International journal of cancer
Published: January 15, 2018
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.
Journal: International journal of cancer
Published: December 22, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026